Effective inhibition of melanosome transfer to keratinocytes by lectins and niacinamide is reversible

Experimental Dermatology

Volumn 14, Issue 7, 2005, Pages 498-508

  Greatens, Amanda ^a,b   Hakozaki, Tomohiro ^c,d   Koshoffer, Amy ^a   Epstein, Howard ^a   Schwemberger, Sandy ^b,e   Babcock, George ^b,e   Bissett, Donald ^f   Takiwaki, Hirotsugu ^d   Arase, Seiji ^d   Wickett, R Randall ^b   Boissy, Raymond E ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c PROCTER AND GAMBLE COMPANY   (United States)

^d UNIVERSITY OF TOKUSHIMA   (Japan)

^e SHRINERS HOSPITALS FOR CHILDREN   (United States)

^f Skin Technology Division   (United States)

Author keywords

Complexion; Melanocyte; Pigmentation; Skin

Indexed keywords

LECTIN; NEOGLYCOPROTEIN; NICOTINAMIDE;

ADULT; APOPTOSIS; ARTICLE; CELL MEMBRANE; CELL TRANSPORT; CELL TYPE; CELL VIABILITY; CHLOASMA; CLINICAL TRIAL; COCULTURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EPIDERMIS CELL; FEMALE; HUMAN; HUMAN CELL; HYPERPIGMENTATION; IN VITRO STUDY; INHIBITION KINETICS; KERATINOCYTE; LENTIGO; MAJOR CLINICAL STUDY; MELANOCYTE; MELANOSOME; MONOCULTURE; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SKIN PIGMENTATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERPIGMENTATION; KERATINOCYTES; LECTINS; MELANOCYTES; MELANOSOMES; MIDDLE AGED; NIACINAMIDE; SKIN PIGMENTATION;

EID: 21244466736     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0906-6705.2005.00309.x     Document Type: Article

References (38)

1. Seiberg M. Keratinocyte-melanocyte interactions during melanosome transfer. Pigment Cell Res 2001: 14: 236-242.
2. Boissy R E. Melanosome transfer to and translocation in the keratinocyte. Exp Dermatol 2003: 13: 1-8.
3. Hearing V J. Biochemical control of melanogenesis and melanosomal organization. J Invest Dermatol Symp Proc 1999: 4: 24-28.
4. Garcia-Borron J C, Solano F. Molecular anatomy of tyrosinase and its related proteins: beyond the histidine-bound metal catalytic center. Pigment Cell Res 2002: 15: 162-173.
5. Topol B M, Haimes H B, Dubetret L, Bell E. Transfer of melanosomes in a skin equivalent model in vitro. J Invest Dermatol 1986: 87: 642-647.
6. Yamamoto O, Bhawan J. Three modes of melanosome transfers in Caucasian facial skin: hypothesis based on an ultrastructural study. Pigment Cell Res 1994: 7: 158-169.
7. Jimbow K, Sugiyama S. Melanosomal translocation and transfer. In: Norlund J J, Boissy, R E, Hearing, V J, King, R A, Ortonne, J-P, eds. The pigmentary system physiology and pathophysiology. New York: Oxford University Press, 1998: 107-114.
8. Lei T C, Virador V M, Vieira W D, Hearing V J. A melanocyte-keratinocyte coculture model to assess regulators of pigmentation in vitro. Anal Biochem 2002: 305: 260-268.
9. Westerhof W, Nanninga B. Graying of hair in humans: morphological and biological data. In: Burgdorff W H C, Katz S I, eds. Dermatology: Progress and perspectives proceedings of the 18th World Congress of Dermatology. Pearl River, NY: Parthenon Publishing Group, 1992: 508-512.
10. Jimbow K, Fitzpatrick T B, Szabo G, Hori Y. Congenital circumscribed hypomelanosis. A characterization based on electron microscopic study of tuberous sclerosis, nevus depigmentosus and piebaldism. J Invest Dermatol 1975: 64: 50-62.
11. Gilchrest B A, Blog F B, Szabo G. Effects of aging and chronic sun exposure on melanocytes in human skin. J Invest Dermatol 1979: 73: 141-143.
12. Mosher D B, Fitzpatrick T B, Ortonne J-P et al. Disorders of pigmentation. In: Fitzpatrick T B, Eisen A Z, Wolff K, Freedberg I M, Austen K F, eds. Dermatology in general medicine, 3rd ed., Vol. 1. New York: McGraw-Hill, Inc., 1987: 794-876.
13. Nordlund J J, Abdel-Malek Z A. Mechanisms for post-inflammatory hyperpigmentation and hypopigmentation. In: Bagnara, J, ed. Advances in Pigment Cell Research Proceedings of the XIII International Pigment Cell Society. New York, NY: Alan R. Liss, Inc., 1988: 219-236.
14. Tyack Z F, Pegg S, Ziviani J. Postburn dyspigmentation: its assessment, management, and relationship to scarring - a review of the literature. J Burn Care Rehabil 1997: 18: 435-440.
15. Seiberg M, Paine C, Sharlow E et al. Inhibition of melanosome transfer results in skin lightening. J Invest Dermatol 2000: 115: 162-167.
16. Hakozaki T, Minwalla L, Zhuang J et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol 2002.
17. Monsigny M, Roche A C, Kieda C, Midoux P. Obrenovich A. Characterization and biological implications of membrane lectins in tumor, lymphoid and myeloid cells. Biochimie 1988: 70: 1633-1649.
18. Auger M J, Ross J A. The biology of the macrophage. In: Lewis C E, McGee J O D, eds. The natural immune system of the macrophage. Oxford: Oxford University Press, 1992: 16-33.
19. Cerdan D, Redziniak G, Bourgeois C A, Monsigny M, Kieda C. C32 human melanoma endogenous lectins: characterization and implication in vesicle-mediated melanin transfer to keratinocytes. Exp Cell Res 1992: 203: 164-173.
20. Stibler H, Westerberg B, Hanefeld F, Hagberg B. Carbohydrate-deficient glycoprotein (CDG) syndrome - a new variant, type III. Neuropediatrics 1993: 24: 51-52.
21. Minwalla L, Zhao Y, Cornelius J et al. Inhibition of melanosome transfer from melanocytes to keratinocytes by lectins and neoglycoproteins in an in vitro model system. Pigment Cell Res 2001: 14: 185-194.
22. Minwalla L, Zhao Y, Le Poole I C, Wickett R R, Boissy R E. Keratinocytes play a role in regulating distribution patterns of recipient melanosomes in vitro. J Invest Dermatol 2001: 117: 341-347.
23. Miyamoto K, Takiwaki H, Hillebrand G G, Arase S. Development of a digital imaging system for objective measurement of hyperpigmented spots on the face. Skin Res Technol 2002: 8: 227-235.
24. Seiberg M, Paine C, Sharlow E et al. The protease-activated receptor-2 regulates pigmentation via keratinocyte-melanocyte interactions. Exp Cell Res 2000: 254: 25-32.
25. Sharlow E, Paine C, Eisinger M, Shapiro S, Seiberg M. The protease-activated receptor-2 upregulates keratinocyte phagocytosis. J Cell Sci 2000: 113: 3093-3101.
26. Scott G, Deng A, Rodriguez-Burford C et al. Protease-activated receptor 2, a receptor involved in melanosome transfer, is upregulated in human skin by ultraviolet irradiation. J Invest Dermatol 2001: 117: 1412-1420.
27. Condaminet B, Redzininiak G, Kieda C. Ultraviolet rays induced expression of lectins on the surface of a squamous carcinoma keratinocyte cell line. Exp Cell Res 1997: 232: 216-224.
28. Draelos Z D. Vitamins and their cutaneous effects. Cosmetic Dermatol 1999: 12: 17-20.
29. Darby W J, McNutt K W, Todhunter E N. Niacin. Nutr Rev 1975: 33: 289-297.
30. Horwitt M K. Niacin. In: Goodhart R S, Shils M E, eds. Modern nutrition in health and diseases. Philadelphia: Lea & Febiger, 1980: 204-208.
31. Sheretz E F, Goldsmith L A. Nutritional influences on the skin. In: Goldsmith L A, ed. Physiology, biochemistry and molecular biology of the skin, 2nd ed., Vol. 2. New York: Oxford University Press, 1991: 1315-1316.
32. Shalita A R, Smith J G, Parish L C, Sofman M S, Chalker D K. Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris. Int J Dermatol 1995: 34: 434-437.
33. Gensler H L. Prevention of photoimmunosuppression and photocarcinogenesis by topical nicotinamide. Nutr Cancer 1997: 29: 157-162.
34. Tanno O, Ota Y, Kitamura N, Katsube T, Inoue S. Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier. Br J Dermatol 2000: 143: 524-531.
35. Imokawa G, Miyagishi M, Yada Y. Endothelin-1 as a new melanogen: coordinated expression of its gene and the tyrosinase gene in UVB-exposed human epidermis. J Invest Dermatol 1995: 105: 32-37.
36. Graeven U, Herlyn M. In vitro growth patterns of normal human melanocytes and melanocytes from different stages of melanoma progression. J Immunother 1992: 12: 199-202.
37. van Muijen G N, Ruiter D J, Hoefakker S, Johnson J P. Monoclonal antibody PAL-M1 recognizes the transferrin receptor and is a progression marker in melanocytic lesions. J Invest Dermatol 1990: 95: 65-69.
38. Halaban R, Langdon R, Birchall N et al. Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes. J Cell Biol 1988: 107: 1611-1619.